News and Events


Stay up-to-date with our latest news, developments and events

Latest News


 

News

DefiniGEN achieves Cyber Essentials certification

News

DefiniGEN secures ISO 9001:2015 recertification

News

The FDA Modernization Act 2.0 – Reducing animal use in drug development.

News

DefiniGEN to showcase Phenotypic Screening Services at SLAS 2023

News

Discover the screening approach which utilizes fully validated A1ATD iPSC-derived hepatocyte cells.

News

DefiniGEN appoints Dr Chris Kirton as Chief Executive Officer

News

DefiniGEN Achieves ISO 9001: (2015) Certification

News

DefiniGEN Secures £3.25 million in Funding to Fast-Track Growth

News

DefiniGEN appoints Dr Ben Cons as Chairman of its Board

News

DefiniGEN launches tool for coronavirus-specific intestinal cell research

News

InSphero and DefiniGEN Receive Eurostars Grant to Develop Human Stem Cell-derived Screening Platform for Diabetes Drug Discovery

Events

 

Events

SLAS2023 International Conference and Exhibition

Events

SOT 62nd Annual Meeting and ToxExpo 3rd February 2023

Events

ELRIG Drug Discovery 2022

Events

Cell & Gene Meeting on the Mesa

Events

DefiniGEN has been confirmed as a Silver sponsor for Discovery US: In Person.

Events

Harnessing the Potential of Next-Generation Disease Models with CRISPR - Webinar

Events

Oxford Global Drug Discovery 2021

Events

ELRIG - CRISPR in Drug Discovery 2020
definigen-logo-background-overlay
Advance your scientific discoveries with our disease model development and screening services.